These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2961751)

  • 21. Assay of the GM2-ganglioside cleaving hexosaminidase activity of skin fibroblasts for GM2-gangliosidoses.
    Harzer K
    Clin Chim Acta; 1983 Nov; 135(1):89-93. PubMed ID: 6228344
    [No Abstract]   [Full Text] [Related]  

  • 22. Degradation of membrane-bound ganglioside GM2 by beta -hexosaminidase A. Stimulation by GM2 activator protein and lysosomal lipids.
    Werth N; Schuette CG; Wilkening G; Lemm T; Sandhoff K
    J Biol Chem; 2001 Apr; 276(16):12685-90. PubMed ID: 11278374
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biochemical basis of type AB GM2 gangliosidosis in a Japanese spaniel.
    Ishikawa Y; Li SC; Wood PA; Li YT
    J Neurochem; 1987 Mar; 48(3):860-4. PubMed ID: 2949061
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnosis of Tay-Sachs disease using [3H]N-acetylneuraminic acid labelled GM2 ganglioside as substrate.
    Poulos A; Holding J; Carey WF
    Clin Chim Acta; 1982 Apr; 120(3):331-40. PubMed ID: 6210469
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence for the presence of two separate protein activators for the enzymic hydrolysis of GM1 and GM2 gangliosides.
    Li SC; Nakamura T; Ogamo A; Li YT
    J Biol Chem; 1979 Nov; 254(21):10592-5. PubMed ID: 115863
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Specificity of mouse GM2 activator protein and beta-N-acetylhexosaminidases A and B. Similarities and differences with their human counterparts in the catabolism of GM2.
    Yuziuk JA; Bertoni C; Beccari T; Orlacchio A; Wu YY; Li SC; Li YT
    J Biol Chem; 1998 Jan; 273(1):66-72. PubMed ID: 9417048
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ganglioside GM2 N-acetyl-beta-D-galactosaminidase and asialo GM2 (GA2) N-acetyl-beta-D-galactosaminidase; studies in human skin fibroblasts.
    O'Brien JS; Norden GW; Miller AL; Frost RG; Kelly TE
    Clin Genet; 1977 Mar; 11(3):171-83. PubMed ID: 13950
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Complexing of glycolipids and their transfer between membranes by the activator protein for degradation of lysosomal ganglioside GM2.
    Conzelmann E; Burg J; Stephan G; Sandhoff K
    Eur J Biochem; 1982 Apr; 123(2):455-64. PubMed ID: 6210531
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A single site in human beta-hexosaminidase A binds both 6-sulfate-groups on hexosamines and the sialic acid moiety of GM2 ganglioside.
    Sharma R; Bukovac S; Callahan J; Mahuran D
    Biochim Biophys Acta; 2003 Jan; 1637(1):113-8. PubMed ID: 12527415
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ganglioside loading of cultured fibroblasts: a provocative method for the diagnosis of the GM2 gangliosidoses.
    Charrow J; Binns HJ
    Clin Chim Acta; 1986 Apr; 156(1):41-9. PubMed ID: 2938852
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Substrate binding properties of the human liver hexosaminidase A activator protein.
    Hechtman P; Isaacs C; Smith-Jones L
    Can J Biochem Cell Biol; 1985 Aug; 63(8):830-8. PubMed ID: 2933135
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Canine GM2-gangliosidosis: chemical and enzymatic features.
    Eto Y; Autilio-Gambetti L; McGrath JT
    Adv Exp Med Biol; 1984; 174():431-40. PubMed ID: 6234761
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A selective inhibitor Gal-PUGNAc of human lysosomal beta-hexosaminidases modulates levels of the ganglioside GM2 in neuroblastoma cells.
    Stubbs KA; Macauley MS; Vocadlo DJ
    Angew Chem Int Ed Engl; 2009; 48(7):1300-3. PubMed ID: 19130519
    [TBL] [Abstract][Full Text] [Related]  

  • 34. GM2-ganglioside metabolism in hexosaminidase A deficiency states: determination in situ using labeled GM2 added to fibroblast cultures.
    Raghavan SS; Krusell A; Krusell J; Lyerla TA; Kolodny EH
    Am J Hum Genet; 1985 Nov; 37(6):1071-82. PubMed ID: 2934978
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ganglioside GM2 levels in human melanoma cells: inverse correlation with lysosomal beta-hexosaminidase A activity.
    Hoon DS; Kaback MM; Lim-Steele J; Tsuchida T; Morton DL; Irie RF
    Biochem Int; 1992 Jul; 27(2):343-52. PubMed ID: 1386984
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Localization of UDP-GalNAc:NeuAc alpha 2,3Gal-R beta 1,4(GalNAc to Gal)N-acetylgalactosaminyltransferase in human stomach. Enzymatic synthesis of a fundic gland-specific ganglioside and GM2.
    Dohi T; Hanai N; Yamaguchi K; Oshima M
    J Biol Chem; 1991 Dec; 266(35):24038-43. PubMed ID: 1748676
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The structural basis for the susceptibility of gangliosides to enzymatic degradation.
    Sonnino S; Brocca P; Acquotti D; Bernardi A; Raimondi L; Kiso M; Ishida H; Li SC; Li YT
    Biosci Rep; 1999 Jun; 19(3):163-8. PubMed ID: 10513893
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of an active acidic residue in the catalytic site of beta-hexosaminidase.
    Tse R; Vavougios G; Hou Y; Mahuran DJ
    Biochemistry; 1996 Jun; 35(23):7599-607. PubMed ID: 8652542
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of an activating factor required for hydrolysis of Gm2 ganglioside catalyzed by hexosaminidase A.
    Hechtman P
    Can J Biochem; 1977 Apr; 55(4):315-24. PubMed ID: 858083
    [TBL] [Abstract][Full Text] [Related]  

  • 40. AB variant of infantile GM2 gangliosidosis: deficiency of a factor necessary for stimulation of hexosaminidase A-catalyzed degradation of ganglioside GM2 and glycolipid GA2.
    Conzelmann E; Sandhoff K
    Proc Natl Acad Sci U S A; 1978 Aug; 75(8):3979-83. PubMed ID: 99746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.